BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6127885)

  • 1. Metabolic effects of prenalterol in diabetic patients.
    Oltmanns D
    Acta Med Scand Suppl; 1982; 659():147-55. PubMed ID: 6127885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA; Oltmanns D
    Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effects of prenalterol in healthy subjects.
    Johnsson G
    Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A; Klein G; Bibra HV; Sauer E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of prenalterol in healthy volunteers.
    Klein G; Wirtzfeld A; Schmidt G; Zilker T
    Acta Med Scand Suppl; 1982; 659():137-46. PubMed ID: 6127884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
    Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
    Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
    Kupper W; Schütt M; Bleifeld W
    Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
    Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
    Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
    Tydén H; Johansson L; Nyström SO
    Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hemodynamic actions of prenalterol in left ventricular failure.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.
    Greefhorst AP; van Herwaarden CL
    Eur J Clin Pharmacol; 1983; 24(2):173-8. PubMed ID: 6132819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.
    Rönn O; Fellenius E; Graffner C; Johnsson G; Lundborg P; Svensson L
    Eur J Clin Pharmacol; 1980 Feb; 17(2):81-6. PubMed ID: 6102914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
    Waagstein F; Estrada-Yamamoto M; Reiz S; Reyes C; Hjalmarson A
    Acta Med Scand Suppl; 1982; 659():221-31. PubMed ID: 6127891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous prenalterol in acute and chronic heart failure.
    Kirlin PC; Pitt B; Lucchesi BR
    Acta Med Scand Suppl; 1982; 659():263-86. PubMed ID: 6127894
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.
    Andersson T; Heath A; Mattsson H
    Acta Med Scand Suppl; 1982; 659():71-88. PubMed ID: 6127900
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
    Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
    Ek L; Björkman JA; Carlsson E; Johansson B
    Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of prenalterol in patients on dialysis.
    Lustenberger N
    Acta Med Scand Suppl; 1982; 659():157-67. PubMed ID: 6127886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.